Acral Melanoma: Clinical Trials

1 trial for Acral Melanoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Not yet recruiting 1

Follow Acral Melanoma: new trials by email Literature Review of Acral Melanoma trials Research Report on Acral Melanoma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of QL1706 Combined With OH2 Injection in Perioperative Treatment of Stage III Resectable Acral Melanoma
Iparomlimab and Tuvonralimab Injection (QL1706), OH2 Injection(Recombinant Human GM-CSF Oncolytic Type II Herpes Simplex Virus) - Melanoma, Acral Melanoma
Phase 4Not yet recruitingPeking University Cancer Hospital & Institute762026-10-012026-10-02

Narrower conditions

Melanoma (1)

Broader conditions

Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Neuroectodermal Tumors (1)  ·  Neuroendocrine Tumors (1)  ·  Nevi and Melanomas (1)  ·  Skin Diseases (1)  ·  Skin Neoplasms (1)  ·  Skin and Connective Tissue Diseases (1)

Sponsors

Peking University Cancer Hospital & Institute (1)